A4GALT

alpha 1,4-galactosyltransferase (P blood group), the group of Alpha 1,4-glycosyltransferases|Blood group antigens

Basic information

Region (hg38): 22:42692121-42721298

Previous symbols: [ "P1" ]

Links

ENSG00000128274NCBI:53947OMIM:607922HGNC:18149Uniprot:Q9NPC4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Blood group, P1PK systemBGHematologicVariants associated with a blood group may be important in specific situations (eg, related to transfusion)Hematologic10993874

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the A4GALT gene.

  • not_provided (63 variants)
  • not_specified (55 variants)
  • p_phenotype (6 variants)
  • Blood_group,_P1PK_system (4 variants)
  • A4GALT-related_disorder (4 variants)
  • Infantile_cortical_hyperostosis (1 variants)
  • NOR_polyagglutination_syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the A4GALT gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017436.7. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
19
clinvar
4
clinvar
23
missense
1
clinvar
86
clinvar
5
clinvar
3
clinvar
95
nonsense
2
clinvar
2
start loss
0
frameshift
4
clinvar
4
splice donor/acceptor (+/-2bp)
0
Total 1 0 92 24 7
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
A4GALTprotein_codingprotein_codingENST00000401850 129178
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000007670.3111257080281257360.000111
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1872412331.030.00001762248
Missense in Polyphen7178.1160.9089877
Synonymous-0.9901241111.120.00000928750
Loss of Function0.14588.460.9463.72e-790

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003660.000362
Ashkenazi Jewish0.000.00
East Asian0.0005440.000381
Finnish0.000.00
European (Non-Finnish)0.00009870.0000967
Middle Eastern0.0005440.000381
South Asian0.00006790.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Necessary for the biosynthesis of the Pk antigen of blood histogroup P. Catalyzes the transfer of galactose to lactosylceramide and galactosylceramide. Necessary for the synthesis of the receptor for bacterial verotoxins.;
Pathway
Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human);Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human);Globo Sphingolipid Metabolism (Consensus)

Recessive Scores

pRec
0.222

Intolerance Scores

loftool
rvis_EVS
-0.29
rvis_percentile_EVS
33.34

Haploinsufficiency Scores

pHI
0.102
hipred
N
hipred_score
0.242
ghis
0.595

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.101

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
A4galt
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;

Gene ontology

Biological process
globoside biosynthetic process;protein glycosylation;glycosphingolipid biosynthetic process;plasma membrane organization
Cellular component
membrane;integral component of Golgi membrane
Molecular function
galactosyltransferase activity;toxic substance binding;lactosylceramide 4-alpha-galactosyltransferase activity